4Mebazaa A,Nieminen MS,Filippatos GS,et al. Levosimendan vs.dobutamine: outcomes for acute heart failure patients on 13-blockersin SURVIVE[J].Euro J Heart fail,2009,(ll): 304-311.
5Parissis JT, Andreadou I,Bistola V, et al. Novel biologic mechanisms of levosimendan and its effect on the failing heart[J]. Expert Opin lnvestig Drugs,2008,(17): 1143-1150.